Additional file 5 of The genomic alterations in glioblastoma influence the levels of CSF metabolites

Supplementary Material 5: Significance values and fold change values for: metabolites that are significantly different and meet the fold change cutoff (+/-1) between pre-treatment and post-treatment GBM samples; all measured CSF metabolites between male and female patients in the GBM cohort; all measured CSF metabolites between male and female patients in the pre-treatment GBM cohort; and all measured CSF metabolites between pre-treatment and post-treatment samples in the GBM-male-only cohort补充材料5：包含以下四类对象的显著性值与倍数变化值：治疗前后胶质母细胞瘤（Glioblastoma, GBM）样本中存在显著差异且符合±1倍数变化阈值的代谢物；胶质母细胞瘤队列中男性与女性患者的所有实测脑脊液（Cerebrospinal Fluid, CSF）代谢物；治疗前胶质母细胞瘤队列中男性与女性患者的所有实测脑脊液代谢物；仅男性胶质母细胞瘤队列中治疗前后样本的所有实测脑脊液代谢物。